title: HeRO Vascular Access Device.
abstract: Chronic hemodialysis via a tunneled dialysis catheter (TDC) is associated with a high incidence of infectious complications and increased mortality and, therefore, should only be considered when all other options for vascular access are exhausted. The Hemoaccess Reliable Outflow (HeRO) Vascular Access Device (Hemosphere, Inc., Minneapolis, MN) is an alternative to the TDC. Early results suggests that the infectious complications are significantly less for the HeRO device when compared to the TDC, and the secondary patency for the device approximates that for prosthetic accesses. The device can be successfully placed in >90% of catheter-dependent patients. Chronic hemodialysis via the HeRO Device is preferable to TDC use.
authors: Vascular and Transplant Specialists, Virginia Beach, VA 23452, USA. MHGLICKM@sentara.com
authors: Marc H
authors: MH
authors: Glickman
mesh_terms: D001807:Blood Vessel Prosthesis / Q000009:adverse effects; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D055499:Catheter-Related Infections / Q000209:etiology; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation; D002408:Catheters, Indwelling / Q000009:adverse effects; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006801:Humans; D018579:Patient Selection; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000209:etiology; D006435:Renal Dialysis; D016896:Treatment Outcome; D014654:Vascular Patency